Consortium partners

Beneficiary receiving EU funding

mymetics-logo-site

MYMETICS BV
Expertise: R&D on virosome formulations

Project responsability: Investigating and compiling the results about the physical and biochemical properties of the virosome-based vaccines obtained by spray-drying and lyophilization.

J H Oortwed 21, Leiden, 2333 CH, Netherlands

Toon Stegamn, CSO Mymetics BV (Coordinator)

upperton_logo

UPPERTON LIMITED
Expertise: Non-GMP and GMP Spray drying

Project responsability: Identification of excipients and experimental conditions suitable for virosome spray drying, production of non-GMP and GMP powder forms for nasal and oral delivery.

BioCity Nottingham, Pennyfoot Street, Nottingham NG1 1GF United Kingdom.

Richard Johnson, Director

catalent_logo

CATALENT U.K. SWINDON ZYDIS LIMITED
Expertise: Zydis technology for fast-dissolving tablet, world leader in drug formulation and distribution

Project responsability: Identification of excipients and experimental conditions suitable for virosome lyophylization, according to the Zydis technology, non-GMP and GMP tablets for sublingual delivery.

Frankland road Blagrove, Swindon SN5 8YG, United Kingdom.

Robert Smith, R&D Global Zydis Director

chimera_logo

CHIMERA BIOTEC GMBH
Expertise: Ultra sensitive immunoassays development and bioanalysis based on Imperacer® (Immuno-PCR) technology.

Project responsability: Immunogenicity study in animals with spray-dried and lyophilized virosomes. Imperacer® immunoassay development and evaluation of the vaccine-induced antibody response.

Emil-Figge-Strasse 76A
Dortmund 44227, Germany.

Beena Punnamoottil, Senior Project Manager

Beneficiary not receiving EU funding but supported by Swiss government

The State Secretariat for Education, Research and Innovation (SERI) within the Federal Department of Economic Affairs, Education and Research (EAER).

bachem-logo2


BACHEM AG
Expertise: R&D, non-GMP and GMP manufacturing of API, world supplier

Project responsability: Process Development and manufacture of peptide P1, GMP-grade, including development and validation of analytical methods.

Hauptstrasse 144, Bubendorf 4416, Switzerland.

Markus Schwaller, Business development

mymetics-logo-site

MYMETICS SA
Expertise : Non-GMP and GMP virosome production, clinical development

Project responsability: Excipient selection for liquid virosomes, supervising the non-GMP and GMP manufacturing of the liquid virosomes and development of analytical methods.

Route de la Corniche 4, Epalinges 1066, Switzerland.

Sylvain Fleury, CSO Mymetics Corporation (Scientific Coordinator-Main contact for MACIVIVA)